ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Chemo+Radiation Preserves Voice, RTOG Study Finds

December 26, 2003

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Watson To Head Genome Research

September 30, 1988